Metraipolis › archive › dc_c4ba7a13e321
Association Between Patient-Reported Outcomes and Overall Survival in Patients with Advanced NSCLC Treated with First-Line Cemiplimab-Based Therapy — Europe PMC PMID:41899521
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41899521
- DOI
- 10.3390/cancers18060916
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T12:34:33.958Z
- SHA-256 of the archived text
9ce1f28bca65a8a48a30effbfa063181ece83cb9af0e715c3f180969630e3651- Stable URL of this page
https://metraipolis.com/documento/dc_c4ba7a13e321
How to cite
Association Between Patient-Reported Outcomes and Overall Survival in Patients with Advanced NSCLC Treated with First-Line Cemiplimab-Based Therapy — Europe PMC PMID:41899521 — Europe PMC (en), https://europepmc.org/article/MED/41899521 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c4ba7a13e321 (Metraipolis archive dc_c4ba7a13e321, sha256 9ce1f28bca65a8a48a30effbfa063181ece83cb9af0e715c3f180969630e3651)
BibTeX
@misc{dcc4ba7a13e321,
title = {Association Between Patient-Reported Outcomes and Overall Survival in Patients with Advanced NSCLC Treated with First-Line Cemiplimab-Based Therapy — Europe PMC PMID:41899521},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41899521},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c4ba7a13e321; sha256 9ce1f28bca65a8a48a30effbfa063181ece83cb9af0e715c3f180969630e3651},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41899521. Agents can read the archived copy with the MCP tool read_document.